The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
Cost recovery implementation statement: Over the counter medicines, from 1 January 2016
Version 2.0, December 2015
This CRIS provides information on how the Therapeutic Goods Administration (TGA) implements cost recovery associated with the registration or listing of over the counter medicines (OTC) onto the Australian Register of Therapeutic Goods (ARTG) and the ongoing monitoring and surveillance of OTC medicines registered or listed on the ARTG.
It also reports financial and non-financial performance information and contains financial forecasts for 2015-16.
The TGA will maintain the CRIS until the activity or cost recovery for the activity has been discontinued.